Gene Polymorphism Association with Type 2 Diabetes and Related Gene-Gene and Gene-Environment Interactions in a Uyghur Population

Background We investigated the association between 8 single-nucleotide polymorphisms (SNPs) at 3 genetic loci (CDKAL1, CDKN2A/2B and FTO) with type 2 diabetes (T2D) in a Uyghur population. Material/Methods A case-control study of 879 Uyghur patients with T2D and 895 non-diabetic Uyghur controls was conducted at the Hospital of Xinjiang Medical University between 2010 and 2013. Eight SNPs in CDKAL1, CDKN2A/2B and FTO were analyzed using Sequenom MassARRAY®SNP genotyping. Factors associated with T2D were assessed by logistic regression analyses. Gene-gene and gene-environment interactions were analyzed by generalized multifactor dimensionality reduction. Results Genotype distributions of rs10811661 (CDKN2A/2B), rs7195539, rs8050136, and rs9939609 (FTO) and allele frequencies of rs8050136 and rs9939609 differed significantly between diabetes and control groups (all P<0.05). While rs10811661, rs8050136, and rs9939609 were eliminated after adjusting for covariates (P>0.05), rs7195539 distribution differed significantly in co-dominant and dominant models (P<0.05). In gene-gene interaction analysis, after adjusting for covariates the two-locus rs10811661-rs7195539 interaction model had a cross-validation consistency of 10/10 and the highest balanced accuracy of 0.5483 (P=0.014). In gene-environment interaction analysis, the 3-locus interaction model TG-HDL-family history of diabetes had a cross-validation consistency of 10/10 and the highest balanced accuracy of 0.7072 (P<0.001). The 4-locus interaction model, rs7195539-TG-HDL-family history of diabetes had a cross-validation consistency of 8/10 (P<0.001). Conclusions Polymorphisms in CDKN2A/2B and FTO, but not CDKAL1, may be associated with T2D, and alleles rs8050136 and rs9939609 are likely risk alleles for T2D in this population. There were potential interactions among CDKN2A/2B (rs10811661) – FTO (rs7195539) or FTO (rs7195539)-TG-HDL-family history of diabetes in the pathogenesis of T2D in a Uyghur population.

[1]  F. Takeuchi,et al.  Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population , 2009, Diabetes.

[2]  Jiang He,et al.  Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.

[3]  K. Tomizawa,et al.  Functional loss of Cdkal1, a novel tRNA modification enzyme, causes the development of type 2 diabetes. , 2011, Endocrine journal.

[4]  T. Hudson,et al.  A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.

[5]  T. Hansen,et al.  Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance. , 2008, The Journal of clinical endocrinology and metabolism.

[6]  K. Ligon,et al.  p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.

[7]  G. Puavilai,et al.  Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. , 1999, Diabetes research and clinical practice.

[8]  C. Gieger,et al.  Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 Genes Confer Risk of Type 2 Diabetes Independently of BMI in the German KORA Studies , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[9]  Jun Zhu,et al.  A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. , 2007, American journal of human genetics.

[10]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[11]  Inês Barroso,et al.  The genetics of obesity: FTO leads the way , 2010, Trends in genetics : TIG.

[12]  A. Theamboonlers,et al.  Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs1800566) genes in Thai cervical cancer patients with HPV 16 infection. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[13]  M. McCarthy,et al.  Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.

[14]  R. Qi,et al.  Identification of a Neuronal Cdk5 Activator-binding Protein as Cdk5 Inhibitor* , 2002, The Journal of Biological Chemistry.

[15]  M. Itakura,et al.  Hypoplasia of endocrine and exocrine pancreas in homozygous transgenic TGF-β1 , 2005, Molecular and Cellular Endocrinology.

[16]  [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. , 2007, Zhonghua xin xue guan bing za zhi.

[17]  S. R. Kulkarni,et al.  FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians , 2009, Diabetologia.

[18]  Q. Wei,et al.  Genetic Variation in MDM2 and p14 ARF and Susceptibility to Salivary Gland Carcinoma , 2012, PloS one.

[19]  K. Hemminki,et al.  Variants at the 9p21 locus and melanoma risk , 2013, BMC Cancer.

[20]  J. H. Moore,et al.  Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. , 2001, American journal of human genetics.

[21]  Xiang Ma,et al.  Type 2 Diabetes in Xinjiang Uygur Autonomous Region, China , 2012, PloS one.

[22]  P. Rizzon,et al.  Effect of family history of type 2 diabetes on the intima-media thickness of the common carotid artery in normal-weight, overweight, and obese glucose-tolerant young adults. , 2003, Diabetes care.

[23]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[24]  L. Groop,et al.  Investigation of Type 2 Diabetes Risk Alleles Support CDKN2A/B, CDKAL1, and TCF7L2 As Susceptibility Genes in a Han Chinese Cohort , 2010, PloS one.

[25]  Chris P. Ponting,et al.  The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase , 2007, Science.

[26]  M. Permutt,et al.  Post Genome-Wide Association Studies of Novel Genes Associated with Type 2 Diabetes Show Gene-Gene Interaction and High Predictive Value , 2008, PloS one.

[27]  K. Mikoshiba,et al.  Cdk5-dependent regulation of glucose-stimulated insulin secretion , 2005, Nature Medicine.

[28]  S. Choudhry,et al.  Contribution of Common Genetic Variation to the Risk of Type 2 Diabetes in the Mexican Mestizo Population , 2012, Diabetes.

[29]  T. Pelikanova,et al.  Tagging rs10811661 variant at CDKN2A/2B locus is not associated with type 2 diabetes mellitus in Czech population. , 2013, Folia biologica.

[30]  M. Muiesan,et al.  Endothelial Function in Pre-diabetes, Diabetes and Diabetic Cardiomyopathy: A Review , 2014 .

[31]  A. Chobanian,et al.  Guidelines for the Management of Hypertension. , 2017, The Medical clinics of North America.

[32]  Hongbing Shen,et al.  Genetic variant in fat mass and obesity-associated gene associated with type 2 diabetes risk in Han Chinese , 2013, BMC Genetics.

[33]  Q. Wei,et al.  Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma. , 2013, Surgery.

[34]  T. Hansen,et al.  Low Physical Activity Accentuates the Effect of the FTO rs9939609 Polymorphism on Body Fat Accumulation , 2008, Diabetes.

[35]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[36]  Hongbing Shen,et al.  Cumulative Effect and Predictive Value of Genetic Variants Associated with Type 2 Diabetes in Han Chinese: A Case-Control Study , 2015, PloS one.

[37]  W. Almawi,et al.  Replication study of common variants in CDKAL1 and CDKN2A/2B genes associated with type 2 diabetes in Lebanese Arab population. , 2012, Diabetes research and clinical practice.

[38]  T. Frayling.  Genome–wide association studies provide new insights into type 2 diabetes aetiology , 2007, Nature Reviews Genetics.

[39]  R. T. Lie,et al.  FTO, Type 2 Diabetes, and Weight Gain Throughout Adult Life , 2011, Diabetes.

[40]  T. Wong,et al.  FTO Variants Are Associated With Obesity in the Chinese and Malay Populations in Singapore , 2008, Diabetes.

[41]  N. Kato.  Insights into the genetic basis of type 2 diabetes , 2013, Journal of diabetes investigation.

[42]  J. Habener,et al.  Inhibition of Cyclin-dependent Kinase 5 Activity Protects Pancreatic Beta Cells from Glucotoxicity* , 2006, Journal of Biological Chemistry.

[43]  Hu Yong-hu.  Recent advances in applications of multifactor dimensionality reduction for detecting gene-gene interactions , 2007 .

[44]  Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. , 1979, Circulation.

[45]  Cheng Hu,et al.  PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 Are Associated with Type 2 Diabetes in a Chinese Population , 2009, PloS one.

[46]  S. Lai,et al.  Association study of genetic variants of 17 diabetes‐related genes/loci and cardiovascular risk and diabetic nephropathy in the Chinese She population (中国畲族人群17个糖尿病相关基因位点的遗传变异与心血管风险和糖尿病肾病的相关性) , 2013, Journal of diabetes.

[47]  P. Froguel,et al.  Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population , 2007, Diabetologia.

[48]  Yingying Luo,et al.  Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in Type 2 Diabetes in a Chinese population , 2010, BMC Medical Genetics.

[49]  E. Kang,et al.  Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population , 2008, Journal of Human Genetics.

[50]  J. Shaw,et al.  Global estimates of diabetes prevalence for 2013 and projections for 2035. , 2014, Diabetes Research and Clinical Practice.